Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-012956
Date:2021-03-18
Issuer: BLACK DIAMOND THERAPEUTICS, INC. (BDTX)
Original Submission Date:

Reporting Person:

SHAH RAJEEV M.
C/O BLACK DIAMOND THERAPEUTICS, INC.
ONE MAIN STREET, 10TH FLOOR CAMBRIDGE, MA 02142

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-03-18 A 443 a $24.01 443 f3 direct
COMMON STOCK 2021-03-18 0 $0.00 1,924,164 indirect f4
COMMON STOCK 2021-03-18 0 $0.00 311,926 indirect f5
COMMON STOCK 2021-03-18 0 $0.00 353,814 indirect f6
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 these shares were issued in accordance with the issuer's amended and restated non-employee director compensation policy, pursuant to which the reporting person elected to receive shares of the issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the issuer.
f2 the price of reported in column 4 is based upon the closing market price of the issuer's common stock on march 18, 2021.
f3 under the reporting person's arrangement with ra capital management, l.p. (the "adviser"), the reporting person holds the shares for the benefit of the ra capital healthcare fund, l.p. (the "fund"), ra capital nexus fund, l.p. (the "nexus fund") and a separately managed account (the "account"). the reporting person is obligated to turn over to the adviser any net cash or stock received as compensation from the issuer, which will offset advisory fees owed by the fund, the nexus fund and the account to the adviser. the reporting person therefore disclaims beneficial ownership of the common stock.
f4 shares held by ra capital healthcare fund, l.p. (the "fund"). ra capital management, l.p. (the "adviser") is the investment manager for the fund. the general partner of the adviser is ra capital management gp, llc (the "adviser gp"), of which mr. shah is a managing member. mr. shah disclaims beneficial ownership of the reported securities held by the fund except to the extent of his pecuniary interest therein.
f5 shares held by ra capital nexus fund, l.p. (the "nexus fund"). the adviser is the investment manager for the nexus fund. the general partner of the adviser is the adviser gp, of which mr. shah is a managing member. mr. shah disclaims beneficial ownership of the reported securities held by the nexus fund except to the extent of his pecuniary interest therein.
f6 shares held in an account owned by a separately managed account (the "account"). the adviser is the investment manager for the account. the general partner of the adviser is the adviser gp, of which mr. shah is a managing member. mr. shah has no pecuniary interest in the reported securities held in the account and therefore disclaims beneficial ownership of those securities.
WhaleWisdom Logo

Elevate your investments